Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. 12. Mai 2024 · During a House Energy and Commerce Committee hearing on Wednesday, Rep. Debbie Lesko (R-AZ) questioned witnesses about bias at NPR, and accountability for the outlet. Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with ...

    • 6 Min.
    • 1198
    • Forbes Breaking News
  2. Vor 6 Tagen · Debbie Lesko. Republican. Since May 7, 2018. View District Map. 9 th District Paul Gosar. Republican. Since Jan 3, 2023. View District Map. All representatives serve until the end of the current Congress on Jan 3, 2025. Map of Congression ...

  3. 17. Mai 2024 · At a House Covid Committee hearing on Thursday, Rep. Debbie Lesko (R-AZ) spoke about gain of function research. Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video ...

    • 5 Min.
    • Forbes Breaking News
  4. 23. Mai 2024 · At yesterday's House Oversight Committee hearing, Rep. Debbie Lesko (R-AZ) questioned Dr. David Morens, Dr. Anthony Fauci's top aides at the NIAID, about his...

  5. 16. Mai 2024 · At a House Covid Committee hearing on Thursday, Rep. Debbie Lesko (R-AZ) spoke about gain of function research. Fuel your success with Forbes. Gain unlimited...

    • 5 Min.
    • 3,1K
    • Forbes Breaking News
  6. Congressman Juan Ciscomani today announced the formation of a diverse group of community leaders who will serve as a sounding board as he represents Arizona’s 6th Congressional District in the U.S. House of Representatives.

  7. 3. Mai 2024 · On Thursday, U.S. Congresswoman Debbie Lesko (AZ-08) introduced the Fixing Administrations Unethical Corrupt Influence Act (FAUCI Act).This legislation prohibits former employees of covered health agencies from serving on the board of entities involved in the development and research of a drug, biological product, or device; or profiting from such development and research.